A detailed history of State Street Corp transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, State Street Corp holds 2,321,248 shares of WVE stock, worth $33.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,321,248
Previous 2,263,426 2.55%
Holding current value
$33.1 Million
Previous $11.3 Million 68.53%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.12 - $9.01 $296,048 - $520,976
57,822 Added 2.55%
2,321,248 $19 Million
Q2 2024

Aug 14, 2024

BUY
$4.38 - $6.48 $3.28 Million - $4.85 Million
749,007 Added 49.46%
2,263,426 $11.3 Million
Q1 2024

May 15, 2024

BUY
$3.54 - $6.84 $887,442 - $1.71 Million
250,690 Added 19.84%
1,514,419 $9.34 Million
Q4 2023

Feb 14, 2024

BUY
$4.16 - $6.87 $286,965 - $473,906
68,982 Added 5.77%
1,263,729 $6.38 Million
Q3 2023

Nov 14, 2023

BUY
$3.56 - $5.75 $37,244 - $60,156
10,462 Added 0.88%
1,194,747 $6.87 Million
Q2 2023

Aug 14, 2023

BUY
$3.51 - $4.69 $3.28 Million - $4.38 Million
933,688 Added 372.59%
1,184,285 $4.31 Million
Q1 2023

May 15, 2023

BUY
$3.58 - $6.3 $120,646 - $212,310
33,700 Added 15.54%
250,597 $1.09 Million
Q4 2022

Feb 14, 2023

BUY
$3.18 - $7.0 $160,590 - $353,500
50,500 Added 30.35%
216,897 $1.52 Million
Q3 2022

Nov 15, 2022

BUY
$2.37 - $4.28 $60,977 - $110,120
25,729 Added 18.29%
166,397 $601,000
Q2 2022

Aug 15, 2022

SELL
$1.23 - $3.25 $688,701 - $1.82 Million
-559,920 Reduced 79.92%
140,668 $457,000
Q1 2022

May 16, 2022

SELL
$2.0 - $3.28 $6,932 - $11,368
-3,466 Reduced 0.49%
700,588 $1.4 Million
Q4 2021

Feb 14, 2022

BUY
$3.14 - $5.15 $91,735 - $150,457
29,215 Added 4.33%
704,054 $2.21 Million
Q3 2021

Nov 15, 2021

BUY
$4.89 - $7.12 $364,026 - $530,034
74,443 Added 12.4%
674,839 $3.31 Million
Q2 2021

Aug 16, 2021

BUY
$5.65 - $7.47 $85,908 - $113,581
15,205 Added 2.6%
600,396 $4 Million
Q1 2021

May 17, 2021

BUY
$5.61 - $12.01 $241,959 - $517,991
43,130 Added 7.96%
585,191 $3.28 Million
Q4 2020

Feb 16, 2021

BUY
$6.99 - $9.26 $551,098 - $730,067
78,841 Added 17.02%
542,061 $4.27 Million
Q3 2020

Nov 10, 2020

SELL
$8.49 - $19.54 $49,759 - $114,523
-5,861 Reduced 1.25%
463,220 $3.93 Million
Q2 2020

Aug 14, 2020

SELL
$7.44 - $11.29 $298,753 - $453,349
-40,155 Reduced 7.89%
469,081 $4.88 Million
Q1 2020

May 11, 2020

BUY
$6.94 - $14.22 $3.53 Million - $7.24 Million
509,236 New
509,236 $4.77 Million

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $1.24B
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.